Clinical impact of FGFR inhibitors on FGFR2 positive pancreatic cancer

被引：1
|
作者：
Stein, Leah
Reeser, Julie W.
Wing, Michele R.
Murugesan, Karthikeyan
Paruchuri, Anoosha
Risch, Zachary
Samorodnitsky, Eric
Hoskins, Emily L.
Smith, Amy
Dao, Thuy
Babcook, Melissa
Imam, Muhammad
Freud, Aharon
Roychowdhury, Sameek
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3395
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
    Gordon, Anderley
    Johnston, Edwina
    Lau, David K.
    Starling, Naureen
    [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 1183 - 1196
  • [2] Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
    Hyung, Sujin
    Han, Boram
    Jung, Jaeyun
    Kim, Seung Tae
    Hong, Jung Yong
    Park, Se Hoon
    Zang, Dae Young
    Park, Joon Oh
    Park, Young Suk
    Kim, Kyoung-Mee
    Kang, Won Ki
    Lee, Jeeyun
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [3] FGFR2 fusion inhibitors: Clinical benefit and mechanisms of resistance
    Borad, Mitesh
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (17)
  • [4] Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma
    Goyal, Lipika
    Saha, Supriya K.
    Liu, Leah Y.
    Siravegna, Giulia
    Leshchiner, Ignaty
    Ahronian, Leanne G.
    Lennerz, Jochen K.
    Vu, Phuong
    Deshpande, Vikram
    Kambadakone, Avinash
    Mussolin, Benedetta
    Reyes, Stephanie
    Henderson, Laura
    Sun, Jiaoyuan Elisabeth
    Van Seventer, Emily E.
    Gurski, Joseph M., Jr.
    Baltschukat, Sabrina
    Schacher-Engstler, Barbara
    Barys, Louise
    Stamm, Christelle
    Furet, Pascal
    Ryan, David P.
    Stone, James R.
    Iafrate, A. John
    Getz, Gad
    Porta, Diana Graus
    Tiedt, Ralph
    Bardelli, Alberto
    Juric, Dejan
    Corcoran, Ryan B.
    Bardeesy, Nabeel
    Zhu, Andrew X.
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 252 - 263
  • [5] Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients
    Goyal, Lipika
    Saha, Supriya K.
    Liu, Leah Y.
    Siravegna, Giulia
    Leshchiner, Ignaty
    Ahronian, Leanne G.
    Lennerz, Jochen K.
    Phuong Vu
    Mussolin, Benedetta
    Reyes, Stephanie
    Furet, Pascal
    Iafrate, A. John
    Getz, Gad
    Porta, Diana G.
    Tiedt, Ralph
    Bardelli, Alberto
    Juric, Dejan
    Corcoran, Ryan B.
    Bardeesy, Nabeel
    Zhu, Andrew X.
    [J]. CANCER RESEARCH, 2017, 77
  • [6] FGFR2 is required for growth and survival in a rare subset of FGFR2 amplified colorectal cancer
    Mathur, Anjili
    Davis, Lenora
    Di Bacco, Alessandra
    Gazdar, Adi
    Lutterbach, Bart
    [J]. CANCER RESEARCH, 2010, 70
  • [7] Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma
    Diperi, Timothy P.
    Zhao, Ming
    Evans, Kurt W.
    Varadarajan, Kaushik
    Moss, Tyler
    Scott, Stephen
    Kahle, Michael P.
    Byrnes, Charnel C.
    Chen, Huiqin
    Lee, Sunyoung S.
    Halim, Abdel-Baset
    Hirai, Hiroshi
    Wacheck, Volker
    Kwong, Lawrence N.
    Rodon, Jordi
    Javle, Milind
    Meric-Bernstam, Funda
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 (02) : 322 - 334
  • [8] Clinical relevance of FGFR2 amplification in diffuse gastric cancer
    Lau, Wen Min
    Zang, Zhijiang
    Teng, Eileen
    Das, Kakoli
    Yong, Wei Peng
    Teh, Ming
    Chia, Tania
    Tan, Jin Wei
    Tay, Amy
    Shabbir, Asim
    Kono, Koji
    So, Jimmy
    Tan, Patrick
    Chan, Shing Leng
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [9] Therapeutic Potential for FGFR Inhibitors in SOX9-FGFR2 Coexpressing Pancreatic Cancer
    O'Sullivan, Hazel
    Kelleher, Fergal C.
    Lavelle, Maire
    McGovern, Brianan
    Murphy, Jean
    Swan, Niall
    McDermott, Ray
    [J]. PANCREAS, 2017, 46 (08) : E67 - E69
  • [10] FGFR1 and FGFR2 in fibrolamellar carcinoma
    Graham, Rondell P.
    Garcia, Joaquin J.
    Greipp, Patricia T.
    Fritcher, Emily G. Barr
    Kipp, Benjamin R.
    Torbenson, Michael S.
    [J]. HISTOPATHOLOGY, 2016, 68 (05) : 686 - 692
12345